| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.32 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |